252 related articles for article (PubMed ID: 35254390)
21. Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
Pajewski NM; Berlowitz DR; Bress AP; Callahan KE; Cheung AK; Fine LJ; Gaussoin SA; Johnson KC; King J; Kitzman DW; Kostis JB; Lerner AJ; Lewis CE; Oparil S; Rahman M; Reboussin DM; Rocco MV; Snyder JK; Still C; Supiano MA; Wadley VG; Whelton PK; Wright JT; Williamson JD
J Am Geriatr Soc; 2020 Mar; 68(3):496-504. PubMed ID: 31840813
[TBL] [Abstract][Full Text] [Related]
22. Systolic Blood Pressure Time in Target Range and Cognitive Outcomes: Insights From the SPRINT MIND Trial.
Li S; Jiang C; Wang Y; Lai Y; Zhao M; Li Q; Bai Y; Dai W; Guo Q; He L; Guo X; Wang W; Li S; Liu N; Jiang C; Tang R; Sang C; Long D; Du X; Dong J; Anderson CS; Ma C
Hypertension; 2023 Aug; 80(8):1628-1636. PubMed ID: 37165869
[TBL] [Abstract][Full Text] [Related]
23. Association Between Intensive vs Standard Blood Pressure Control and Incident Left Ventricular Conduction Disease: A Post Hoc Analysis of the SPRINT Randomized Clinical Trial.
Frimodt-Møller EK; Vittinghoff E; Kaur G; Biering-Sørensen T; Soliman EZ; Marcus GM
JAMA Cardiol; 2023 Jun; 8(6):612-616. PubMed ID: 37133829
[TBL] [Abstract][Full Text] [Related]
24. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
25. Blood Pressure Is Not Associated With Cerebral Blood Flow in Older Persons.
Foster-Dingley JC; Moonen JE; de Craen AJ; de Ruijter W; van der Mast RC; van der Grond J
Hypertension; 2015 Nov; 66(5):954-60. PubMed ID: 26351027
[TBL] [Abstract][Full Text] [Related]
26. Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY).
White WB; Wakefield DB; Moscufo N; Guttmann CRG; Kaplan RF; Bohannon RW; Fellows D; Hall CB; Wolfson L
Circulation; 2019 Nov; 140(20):1626-1635. PubMed ID: 31607143
[TBL] [Abstract][Full Text] [Related]
27. Association of Midlife Cardiovascular Risk Profiles With Cerebral Perfusion at Older Ages.
Suri S; Topiwala A; Chappell MA; Okell TW; Zsoldos E; Singh-Manoux A; Kivimäki M; Mackay CE; Ebmeier KP
JAMA Netw Open; 2019 Jun; 2(6):e195776. PubMed ID: 31225888
[TBL] [Abstract][Full Text] [Related]
28. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
[TBL] [Abstract][Full Text] [Related]
29. Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials.
Beddhu S; Greene T; Boucher R; Cushman WC; Wei G; Stoddard G; Ix JH; Chonchol M; Kramer H; Cheung AK; Kimmel PL; Whelton PK; Chertow GM
Lancet Diabetes Endocrinol; 2018 Jul; 6(7):555-563. PubMed ID: 29685860
[TBL] [Abstract][Full Text] [Related]
30. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).
Ambrosius WT; Sink KM; Foy CG; Berlowitz DR; Cheung AK; Cushman WC; Fine LJ; Goff DC; Johnson KC; Killeen AA; Lewis CE; Oparil S; Reboussin DM; Rocco MV; Snyder JK; Williamson JD; Wright JT; Whelton PK;
Clin Trials; 2014 Oct; 11(5):532-46. PubMed ID: 24902920
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure: Post Hoc Analysis of a Randomized Clinical Trial.
Qureshi AI; Huang W; Lobanova I; Barsan WG; Hanley DF; Hsu CY; Lin CL; Silbergleit R; Steiner T; Suarez JI; Toyoda K; Yamamoto H;
JAMA Neurol; 2020 Nov; 77(11):1355-1365. PubMed ID: 32897310
[TBL] [Abstract][Full Text] [Related]
32. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial.
Williamson JD; Launer LJ; Bryan RN; Coker LH; Lazar RM; Gerstein HC; Murray AM; Sullivan MD; Horowitz KR; Ding J; Marcovina S; Lovato L; Lovato J; Margolis KL; Davatzikos C; Barzilay J; Ginsberg HN; Linz PE; Miller ME;
JAMA Intern Med; 2014 Mar; 174(3):324-33. PubMed ID: 24493100
[TBL] [Abstract][Full Text] [Related]
33. Effect of Intensive vs Standard Blood Pressure Treatment Upon Erectile Function in Hypertensive Men: Findings From the Systolic Blood Pressure Intervention Trial.
Foy CG; Newman JC; Russell GB; Berlowitz DR; Bates JT; Burgner AM; Carson TY; Chertow GM; Doumas MN; Hughes RY; Kostis JB; Buren PV; Wadley VG;
J Sex Med; 2020 Feb; 17(2):238-248. PubMed ID: 31862174
[TBL] [Abstract][Full Text] [Related]
34. Diastolic Blood Pressure and Intensive Blood Pressure Control on Cognitive Outcomes: Insights From the SPRINT MIND Trial.
Jiang C; Li S; Wang Y; Lai Y; Bai Y; Zhao M; He L; Kong Y; Guo X; Li S; Liu N; Jiang C; Tang R; Sang C; Long D; Du X; Dong J; Anderson CS; Ma C
Hypertension; 2023 Mar; 80(3):580-589. PubMed ID: 36688305
[TBL] [Abstract][Full Text] [Related]
35. Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials.
Oikonomou EK; Spatz ES; Suchard MA; Khera R
Lancet Digit Health; 2022 Nov; 4(11):e796-e805. PubMed ID: 36307193
[TBL] [Abstract][Full Text] [Related]
36. Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.
Beddhu S; Rocco MV; Toto R; Craven TE; Greene T; Bhatt U; Cheung AK; Cohen D; Freedman BI; Hawfield AT; Killeen AA; Kimmel PL; Lash J; Papademetriou V; Rahman M; Rastogi A; Servilla K; Townsend RR; Wall B; Whelton PK;
Ann Intern Med; 2017 Sep; 167(6):375-383. PubMed ID: 28869987
[TBL] [Abstract][Full Text] [Related]
37. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
[TBL] [Abstract][Full Text] [Related]
38. Association Between Baseline Diastolic Blood Pressure and the Efficacy of Intensive vs Standard Blood Pressure-Lowering Therapy.
Foy AJ; Filippone EJ; Schaefer E; Nudy M; Ruzieh M; Dyer AM; Chinchilli VM; Naccarelli GV
JAMA Netw Open; 2021 Oct; 4(10):e2128980. PubMed ID: 34668944
[TBL] [Abstract][Full Text] [Related]
39. Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.
Still CH; Rodriguez CJ; Wright JT; Craven TE; Bress AP; Chertow GM; Whelton PK; Whittle JC; Freedman BI; Johnson KC; Foy CG; He J; Kostis JB; Lash JP; Pedley CF; Pisoni R; Powell JR; Wall BM;
Am J Hypertens; 2017 Dec; 31(1):97-107. PubMed ID: 28985268
[TBL] [Abstract][Full Text] [Related]
40. Blood Pressure Intervention and Control in SPRINT.
Cushman WC; Ringer RJ; Rodriguez CJ; Evans GW; Bates JT; Cutler JA; Hawfield A; Kitzman DW; Nasrallah IM; Oparil S; Nord J; Papademetriou V; Servilla K; Van Buren P; Whelton PK; Whittle J; Wright JT;
Hypertension; 2022 Sep; 79(9):2071-2080. PubMed ID: 35766041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
